Russell Investments Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $394K | Buy |
|
|||||
|
2025
Q2 | $7.13K | Sell |
|
|||||
|
2025
Q1 | $162K | Buy |
|
|||||
|
2024
Q4 | $1.12K | Buy |
|
|||||
|
2024
Q3 | $1.08K | Sell |
|
|||||
|
2024
Q2 | $42.1K | Hold |
|
|||||
|
2024
Q1 | $35.2K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $200 | Sell |
|
|||||
|
2023
Q2 | $1.2M | Sell |
|
|||||
|
2023
Q1 | $2.3M | Sell |
|
|||||
|
2022
Q4 | $2.17M | Sell |
|
|||||
|
2022
Q3 | $1.94M | Sell |
|
|||||
|
2022
Q2 | $2.29M | Buy |
|
|||||
|
2022
Q1 | $4.33M | Buy |
|
|||||
|
2021
Q4 | $5.59M | Buy |
|
|||||
|
2021
Q3 | $1.36M | Buy |
|
|||||
|
2021
Q2 | $2.42M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Sell |
|
|||||
|
2020
Q4 | $1.11M | Sell |
|
|||||
|
2020
Q3 | $2.08M | Sell |
|
|||||
|
2020
Q2 | $3.21M | Buy |
|
|||||
|
2020
Q1 | $736K | Buy |
|
|||||
|
2019
Q4 | $334K | Sell |
|
|||||
|
2019
Q3 | $926K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $61K | Buy |
|